Post-Market
Field Action vs Recall
In one line
Distinction between corrective field actions taken on devices in the field and FDA-defined recall events.
Definition
Field action is a broad operational term for an action involving distributed devices; it is not a single FDA legal classification. Under 21 CFR 7.3(g), a recall is a firm's removal or correction of a marketed product FDA considers violative and against which it would initiate legal action. Market withdrawal and stock recovery are excluded from that definition.
Recall classification and reporting under 21 CFR part 806 are separate questions. Part 806 covers specified manufacturer and importer corrections or removals to reduce a risk to health or remedy a violation that may present a risk to health. It includes exemptions and recordkeeping provisions; calling an action 'not a recall' does not settle the reporting analysis.
Why it matters
Separate three decisions: what practical action is needed, whether the action meets FDA's recall definition, and whether a correction or removal must be reported under part 806. The company's internal label does not answer the other two questions. A customer notification, labeling change or software update can have different implications depending on the facts.
An illustrative assessment records the affected devices and distribution, the observed problem, risk-to-health analysis, any violation and proposed remedy. Apply the recall definition and then the part 806 reporting criteria and exemptions separately. Preserve the rationale and assess applicable recordkeeping even if the correction or removal is not reportable. FDA assigns recall classifications based on health hazard, not merely the technical form of the remedy.
Coordinate quality, regulatory, clinical and service teams so the evidence, communication and effectiveness checks describe the same action. For EU devices, separately assess field safety corrective action and vigilance requirements under the applicable framework; FDA recall terminology is not a one-to-one legal crosswalk. This workflow is illustrative and cannot determine the status of a particular action.
Common pitfalls
- •Calling a software patch 'maintenance' without assessing the problem it remedies.
- •Treating recall classification and part 806 reporting as one decision.
- •Assuming a nonreportable action needs no records.
- •Using a company's field-action label as a regulatory conclusion.
- •Applying EU field safety corrective action terminology as if it were identical to FDA recall rules.
Sources
- 21 CFR 806 · eCFR
- FDA Recalls - Medical Devices · FDA
- EUDAMED Public Site · European Commission
- 21 CFR 7.3, recall definitions · US official source